Background: Mastocytosis is a rare disorder with diverse clinical manifestations. In
INTRODUCTION
Mastocytosis comprises a heterogeneous spectrum of diseases characterized by a range of local and systemic symptoms. The bullous form of mastocytosis is a rare, morbid condition typically encountered in young children [2] . Episodic blistering has been reported in maculopapular CM, which usually occurs after stroking or rubbing of the lesional skin and rarely appears spontaneously [4] . There are also reports of nodular forms with occasional blistering as well as predominant bullous variants of CM. In fact, the long-living bullous manifestations are characteristic of the diffuse CM [3] [4] [5] . It is interesting that in our case, the varied skin lesions, not corresponding to diffuse CM, were associated with an uninterrupted bulla formation for half a year and no improvement with H1 receptor blockers or topical corticosteroids/antibiotics. In our case, the flushing episodes were very frequent, spontaneous, and not induced by any precipitating factor (ambient temperature, food, exercise, stress, medication, etc. In our case, the diagnosis of CM was made based on clinical manifestations, Darier's sign, and histopathological and immunohistochemical findings (anti-c-kit/CD117 with a high specificity and sensitivity for mast cells). It is widely accepted that growth and differentiation and proliferation of mast cells are controlled by the tyrosine kinase receptor c-Kit (CD117) and its ligand stem cell factor. It is also controlled by other cytokines such as IL-4, IL-6, IL-10, and IL-13 [1, 2] . Recent genetic studies have identified new proteins (Lin28b) that are of interest in mast cell disease [7] .
Adequate [11, 12] .
CONCLUSION
Childhood CM usually has a benign course and most of the cases resolve by puberty [2, 3] . With proper treatment and family education on avoiding triggering factors, gradual resolution of both skin lesions and mast cell-mediated symptoms may be observed. Despite the lack of systemic involvement, some patients with CM may develop skin manifestations that are difficult to control. Therefore, follow-up with rigorous evaluation and relevant management is required for each individual case.
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